Skip to main content
. 2019 Feb 13;5(2):eaav2554. doi: 10.1126/sciadv.aav2554

Fig. 4. A combination of NA and phosphatase treatment of the HL-SGM results in no binding of Penn, while single enzymatic treatments allow for binding to certain glycan fractions.

Fig. 4

Binding inhibition with Fv M6P-1 (100 μg/ml) is also shown.